JP2008137998A - Skin ameliorating agent and oral composition for beauty and health - Google Patents

Abstract

<P>PROBLEM TO BE SOLVED: To provide a substance useful for recovery of decrease of extracellular matrix components in the skin tissue caused by ultraviolet ray, active oxygen, aging etc., and ameliorating skin troubles such as wrinkle, chapped skin, etc., and recovery of skin injury, and to provide an industrially available form of the substance composition. <P>SOLUTION: The invention relates to a skin fibroblasts proliferation promoter, a collagen and/or hyaluronic acid production potentiating agent, and a skin aging inhibitor composed of the aqueous component of defatted lees of fruit and/or seed of Camellia japonica belonging to genus Theaceae Camellia, as the active component, and relates to the oral composition, preferably to a food or a drink, for beauty and health composed of at least one of the agents. <P>COPYRIGHT: (C)2008,JPO&INPIT

Description

The present invention relates to a skin improving agent comprising as an active ingredient an aqueous component of camellia (Camellia japonica) fruit and / or seed defatted cocoon belonging to the genus Camellia, and an oral composition for cosmetic health comprising the same. More specifically, the skin improving agent is a dermal fibroblast growth promoter, collagen and / or hyaluronic acid production enhancer, or skin aging inhibitor.

The skin consists of epidermis, dermis and subcutaneous tissue due to its constitution. The epidermis is in contact with the outside world and is composed of the stratum corneum, granule layer, spiny layer, and basal layer, and the keratinocytes (keratinocytes) produced in the basal layer repeat division and undergo horny cells through granule cells. Covers the skin surface, and old keratinocytes become plaque and peel off. The sum of the time required for the keratinocytes to reach the stratum corneum from the basal layer (about 14 days) and the period for protecting the skin surface as keratinocytes (about 14 days) is referred to as turnover as skin metabolism. Unlike the epidermis, the dermis tissue has few cells and is mainly composed of extracellular components such as proteins such as collagen and elastin, and mucopolysaccharides such as hyaluronic acid and chondroitin sulfate. It plays roles such as tissue support, water retention in the interstitial space, skin lubricity and flexibility retention, protection of skin tissue from external factors such as ultraviolet rays, dry environment, mechanical irritation and damage, microbial infection, etc. . These extracellular components are produced by fibroblasts (Non-Patent Document 1).

The extracellular matrix components produced by fibroblasts are routinely denatured and decomposed under the influence of active oxygen and microorganisms or by irradiation with ultraviolet rays, resulting in skin wrinkles, spots, freckles, roughness, rough skin, etc. Causes skin problems. In addition, it is known that various functions of a living body decrease with aging, the tissue ages, and the content of extracellular components such as hyaluronic acid in the skin tissue also decreases (Non-patent Document 2). When the content of hyaluronic acid or collagen in the skin tissue decreases, dry skin, rough skin, decreased elasticity and flexibility, decreased tension and gloss, increased skin wrinkles, sagging and dullness, and skin aging symptoms Wake up. Therefore, in order to maintain healthy skin, it is necessary to replenish the extracellular matrix component. For this purpose, it is desirable to activate fibroblasts, which are the component-producing cells in the dermal tissue.

Attempts to search for an activator of dermal fibroblasts have been studied in the past. Hibiscus extract (Patent Document 1), L-ascorbic acid and its derivatives (Patent Document 2), almond, dandelion, assembly, hop Extract (Patent Document 3), collagen hydrolyzed tripeptide (Patent Document 4), rosemary extract containing Genkwanin (Patent Document 5), α-D-glucopyranosylglycerol (Patent Document 6), A polypeptide having a specific amino acid sequence (Patent Document 7) and the like have been proposed.

These components and extracts are disclosed, for example, as a possibility of being blended in cosmetics and external preparations and applied to the skin. However, there are drawbacks in terms of percutaneous absorption, and they are easily washed away when washing the skin. Therefore, the effect on the skin trouble was not sustained, and the physiological function of the skin tissue was not essentially improved. In addition, when peptides are taken orally, there is a risk of deterioration and degradation in the gastrointestinal tract, and there are few things that can be effective in practical use. Furthermore, depending on the raw materials and components used in combination, the color tone, flavor, physical properties, etc. of the practical product are affected, and the actual situation is not necessarily satisfactory in terms of stability, usage, cost and the like. Therefore, an effective material capable of improving the skin trouble has been demanded.

The following is known about the camellia described later. That is, camellia has a history of being used as an ornamental horticultural plant since ancient times, and fats and oils collected from seeds are used as fuel oil, hair styling, high-grade edible oil, etc., and xylem is ashed to brew sake. The actual defatted rice bran has been used as a fertilizer for agricultural crops. The defatted cocoons contain saponins and tannins, and there are also proposals for processing them into insecticides (Patent Document 8), agricultural and horticultural nematodes control agents (Patent Document 9), and the like. However, there is no example of using the ingredients contained in camellia defatted cocoon for skin improvement.

Japanese Patent Laid-Open No. 9-295928 Japanese National Patent Publication No. 10-509735 Japanese Patent Laid-Open No. 10-36279 JP 2002-255847 A JP 2004-137217 A JP 2004-331578 A JP 2006-265221 A Japanese Patent No. 170071 JP-A-9-30916 Michihiro Hattori, “Science of Skin Care”, pp. 6-14 and pp. 15-83, Hankabo Co., Ltd., published on February 25, 1997 Maria O. Longas et al., “Evidence for structural change in dermatological sulfate and hyaluronic acid with aging” (Netherlands), 1987, Carbohydr. Res. 159, 127-136

In view of the current situation, the present inventors have recovered the reduction of the extracellular matrix component content in the living body, particularly skin tissue, caused by the decrease in metabolic function caused by ultraviolet rays, active oxygen, aging, etc. An object of the present invention is to develop a safe and stable material for preventing and / or improving the trouble and to provide a composition in an aspect that can be effectively used industrially.

In order to solve the above problems, the present inventors have conducted extensive studies on the metabolic mechanism of the extracellular matrix components in the skin tissue and materials that promote its production. Surprisingly, camellia is extremely effective, and it activates dermal fibroblasts, promotes their proliferation, enhances the production of the extracellular matrix components by the cells, and significantly improves skin aging symptoms. The present inventors have found that the components to be obtained are contained, and that they can be effectively used in the fields of foods and drinks, pharmaceuticals, quasi drugs, feeds, etc., and have completed the present invention.

That is, according to the present invention, there is provided a dermal fibroblast proliferation promoter comprising as an active ingredient an aqueous component of camellia (Camellia japonica) berries and / or seed defatted straw belonging to the camellia family Camellia. .

According to the present invention, there is also provided a collagen and / or hyaluronic acid production enhancer comprising, as an active ingredient, an aqueous component of camellia (Camellia japonica) fruit and / or seed defatted cocoon belonging to the camellia family Camellia. Provided. Here, the production enhancement of collagen and / or hyaluronic acid is preferably an increase in the amount of collagen and / or hyaluronic acid in the skin tissue.

According to the present invention, there is further provided an anti-skin aging agent comprising, as an active ingredient, an aqueous component of camellia (Camellia japonica) fruit and / or seed defatted lees belonging to the genus Camellia. Here, it is desirable that skin aging includes at least one symptom selected from the group consisting of skin wrinkles, blemishes, dullness, buckwheat, sagging, roughness, and rough skin.

In each of the above-mentioned agents of the present invention, the aqueous component which is an active ingredient is an extract obtained by subjecting camellia (Camellia japonica) berries and / or seed defatted straw to an extraction treatment with water and / or lower alcohol. It is desirable that

In addition, according to the present invention, an oral composition for beauty and health comprising any one of the above-mentioned skin fibroblast proliferation promoter, collagen and / or hyaluronic acid production enhancer, or skin antiaging agent. Is provided. The oral composition is preferably a food or drink.

In addition, according to the present invention, the dermal fibroblast proliferation promoting action characterized by further ingesting the aqueous component of camellia (Camellia japonica) berries and / or seed defatted koji belonging to the camellia family Camellia There is provided a method for expressing at least one action selected from the group consisting of in vivo collagen and / or hyaluronic acid production enhancing action and skin aging prevention action. Here, skin fibroblast proliferation promotion, in vivo collagen and / or hyaluronic acid production enhancement, and skin aging prevention are the same as described above.

The aqueous component of camellia (Camellia japonica) fruit and / or seed defatted lees according to the present invention is excellent in quality stability, promotes the proliferation of dermal fibroblasts, collagen and / or hyaluronic acid by the fibroblasts It enhances the production of skin and promotes skin turnover to improve skin troubles such as skin wrinkles, spots, dullness, buckwheat, sagging, roughness, and rough skin. In addition, it promotes regeneration of damaged skin and contributes to maintaining skin health. Such an effect is remarkably expressed by orally ingesting or administering the dermal fibroblast growth promoter, collagen and / or hyaluronic acid production enhancer of the present invention, or skin anti-aging agent. Therefore, the respective agents of the present invention improve the skin, particularly in the fields of foods and drinks, pharmaceuticals, quasi-drugs, feeds, etc., in the form of the respective agents or in a form blended with various conventional products in the fields. It is possible to make effective use for this. The respective agents of the present invention can also be applied to products in the fields of cosmetics and external preparations for skin.

The present invention is described in detail below. First, the fibroblast proliferation-promoting agent of the present invention has an action of promoting the proliferation of fibroblasts present in living tissue, particularly the dermal tissue of the skin, and the genus Camellia from Theaceae family. It contains an aqueous component of camellia (Camellia japonica) fruit and / or seed defatted rice bran as an active ingredient.

As the plant belonging to the camellia genus, generally, the camellia camellia belonging to the camellia section, such as Camellia japonica, the tea belonging to the tea section (C. sinensis), the sasanqua belonging to the southern section, C. sasanqua, etc. (C. granthamiana) and the like, and the long-tailed salamander (C. salicifolia) and the like, the Hime Sasanka (C. lutchuensis) and the like belonging to the camellia section are known. Use. Examples of this include C. japonica var. Japonica, C. japonica subsp. Rusticana, C. japonica var. Macrocarpa, C. japonich. Hong Konggenesis, C. reticulata, C. salenensis, Pitaldi var. partardii, and C. partidi var. Yamabe camellia (same kind as Ayaba camellia), wild tea flower (same kind as Ayers camellia), Kushimatsubaki can be mentioned (apple camellia and the like) and the like. What is necessary is just to utilize suitably these camellia which are growing naturally in the Japanese archipelago, the Korean peninsula, the Shandong peninsula of China, etc.

In the present invention, the camellia nuts and / or seeds are subjected to a compression treatment, an extraction treatment using a hydrophobic organic solvent such as hexane or heptane, or a liquefied gas such as liquefied carbon dioxide or liquefied propane. The defatted soot, which is a residue extracted from, is used as an essential raw material. Here, the camellia seeds and / or seeds may be either early-ripening seeds or mature seeds, and these seeds may be used. From the viewpoint of defatted koji and the yield of the active ingredient, mature seeds or seeds thereof may be used. desirable. In the present invention, it is convenient to use seeds obtained from mature fruits dried for about 1-2 weeks in the sun.

The aqueous component of the defatted lees can be produced by any method, but it is preferable to extract it with water and / or lower alcohol. The lower alcohol has a tendency to extract the oily component in the defatted soot as the carbon number increases, so a lower alcohol is desirable, such as methanol, ethanol, normal propanol, isopropanol, normal butanol, isobutanol, etc. It can be illustrated. When using a lower alcohol having a large carbon number, it is preferable to increase the water content in order to suppress the extraction of oily components in the defatted soot. For example, the water content in the case of propanol is about 20 wt% to about 50 wt%, and the water content in the case of butanol is about 40 wt% to about 70 wt%. Desirable extraction solvents are water, methanol and ethanol, and water-containing alcohols thereof (water content: 0 to 100% by weight).

In order to extract the defatted lees, the extraction solvent is added in an amount of about 1 to 30 times by weight with respect to 1 part by weight of the defatted lees, at about normal temperature or 1 to 5 atm. After stirring and mixing for 10 minutes to about 3 hours as necessary, the mixture is cooled to room temperature and filtered, and the filtrate is concentrated and dried by an appropriate means such as drying under reduced pressure, spray drying or freeze drying. The dried product may be appropriately pulverized. In this way, a light yellow to yellow solid which is an aqueous component of the defatted soot according to the present invention can be obtained. The extraction method is preferably performed by repeatedly extracting the extraction residue once extracted, or under a pressure of 1 to 3 atmospheres at about 100 ° C. to about 130 ° C. This increases the yield of the aqueous component according to the present invention. This aqueous component includes saponins, tannins, kaempferol, glycosides thereof and the like.

In the fibroblast growth promoter of the present invention, the aqueous component as its active ingredient is made into a solid, paste or liquid form, which may be used as it is as a fibroblast growth promoter, but if necessary, It can also be prepared by using a conventional method in combination with known additives for applications in which the fibroblast growth promoter of the present invention is used. Here, known additives are preferably those commonly used for ingestion, for example, excipients, binders, disintegrants, lubricants, wetting agents, fluidizing agents, preservatives, surfactants. , Stabilizers, diluents, solubilizers, tonicity agents, bactericides, preservatives, flavoring agents, flavoring agents, coloring agents, fragrances and the like can be used, and the effect of promoting fibroblast proliferation is known Material can be used.

In addition to the materials described in the above-mentioned patent document, the fibroblast proliferation promoting action is known as chlorella, aloe vera, rice, jujube, moon peach, mango ginger, no grape, spinach fern, lotus germ, sesame, chili pepper, toki, Dokudami, Haskup fruit, Kusunohagashi, algae (kaurelpa, racemosa), dried products or extracts of plants and algae such as strawberry, barley, catechins, imino group-containing peptides, α-lipoic acid and its salts, esters, amides, etc. Examples thereof include derivatives, dihydrolipoic acid and derivatives thereof, chitin hydrolysates, N-acetyl-D-glucosamine and oligomers thereof. In addition, this invention is not limited at all by these illustrations.

In addition, the form of the said composition can be made into oral preparations, such as a granule, a tablet, a capsule, and a liquid agent. The content of the aqueous component in such a pharmaceutical composition is difficult to define uniformly depending on the type and content of the combined raw material, but is generally about 0.01% to 90% by weight, more preferably about 0.1% by weight. To about 70% by weight. When the content is less than about 0.01% by weight, the desired effect of the present invention is not recognized. When the content exceeds about 90% by weight, it becomes difficult to prepare a practical pharmaceutical composition and further desired by the present invention. We cannot expect effect. The fibroblast growth promoter of the present invention is preferably used in a mode of being taken or administered orally. A suitable amount of the fibroblast growth-promoting agent of the present invention when taken or administered orally is about 10 mg to about 1,000 mg per day for a human adult based on the aqueous component contained in the agent, desirably About 30 mg to about 500 mg, more desirably about 50 mg to about 300 mg.

Next, the collagen and / or hyaluronic acid production enhancer of the present invention has an action of enhancing the production of collagen and / or hyaluronic acid in the living body, and the genus Camellia from Theaceae family. It contains an aqueous component of camellia (Camellia japonica) fruit and / or seed defatted rice bran as an active ingredient.

Type and site of camellia applied to collagen and / or hyaluronic acid production enhancer of the present invention, defatted koji, extraction method and conditions, aqueous component, blending amount of aqueous component, combined raw material, composition and form, usage method The intake amount and the like are the same as those of the aforementioned fibroblast growth promoter. In the collagen and / or hyaluronic acid production enhancer of the present invention, the production of collagen and / or hyaluronic acid is more desirably the production of collagen and / or hyaluronic acid by fibroblasts in the dermal tissue.

Moreover, the skin antiaging agent of this invention has the effect | action which improves skin trouble and damage, The fruit and / or seed of the camellia (Camellia japonica) which belong to the camellia genus (Camellia) of Theaceae (Theaceae). It contains an aqueous component of defatted soot as an active ingredient.

The types and parts of camellia applied to the skin antiaging agent of the present invention, defatted lees, extraction methods and conditions thereof, aqueous components, blending amounts of aqueous components, combined raw materials, compositions and forms thereof, usage methods, intakes, etc. The same as in the case of the aforementioned fibroblast growth promoter. In the skin antiaging agent of the present invention, the skin aging symptom preferably includes at least one symptom selected from the group consisting of wrinkles, spots, dullness, buckwheat, sagging, roughness and rough skin.

In the present invention, at least one of the aforementioned skin fibroblast proliferation promoter, collagen and / or hyaluronic acid production enhancer and skin anti-aging agent is used as it is in food and drink, pharmaceuticals, quasi drugs, It can be made into various products in the feed and other industrial fields, or can be used in an embodiment used as a part of the blended raw materials of the various products. In particular, an oral composition for beauty and / or health is preferred, and the most preferred embodiment of this oral composition is a food or drink. This example will be described below, but the present invention is not limited thereby.

Specific examples of food and drink include beverages such as vegetable juice, fruit juice drinks, soft drinks, tea, soup, jelly, pudding, yogurt, cake premix products, confectionery, sprinkles, miso, soy sauce, sauce, dressing, mayonnaise, Vegetable cream, seasonings for grilled meat sauce and noodle soup, noodles, udon, soba noodles, spaghetti, processed meat and fish products such as ham and sausage, hamburger, croquette, sprinkle, boiled, jam, milk, cream, butter, spread In addition to various processed foods such as powdered, solid and liquid dairy products such as cheese and cheese, margarine, bread, cakes, cookies, chocolate, candy, gummi, gum, etc., powdered, granular, pills, tablets , Soft capsule, hard capsule, paste or liquid dietary supplement, food for specified health use, functional food , Mention may be made of health food, diet, etc. of the concentrated liquid diet and dysphagia for food.

In order to produce these foods and drinks, at least one of the dermal fibroblast proliferation promoter, collagen and / or hyaluronic acid production enhancer and skin antiaging agent of the present invention and a known raw material are used, or are publicly known. A part of the raw material may be replaced with at least one of the above-mentioned agents and manufactured by a conventional method. For example, the dermal fibroblast growth promoter of the present invention and, if necessary, excipients such as glucose (dextrose), dextrin, lactose, starch or processed product thereof, cellulose powder, vitamins, minerals, animals and plants and fish and shellfish Oils and fats, proteins (proteins derived from plants and animals, hydrolysates thereof, etc.), carbohydrates, pigments, fragrances, antioxidants, surfactants, other edible additives, powders and extracts containing various nutritional functional ingredients Mixed with edible ingredients such as powders, granules, pellets, tablets, etc., processed into ordinary processed foods of the above examples by conventional methods, mixed liquids such as gelatin, sodium alginate, Using capsules such as carboxymethylcellulose to form capsules or processing into beverages (drinks) for use as dietary supplements or health foods It is suitable. In particular, tablets, capsules and drinks are desirable.

The ratio of at least one of the skin fibroblast proliferation promoter, collagen and / or hyaluronic acid production enhancer and skin antiaging agent of the present invention to be blended in such food and drink is the type and form of the food and drink, and the present invention. Although it is difficult to uniformly define the content of the aqueous component according to the present invention in the above-mentioned agent and the difference in the type, component, and blending amount of other ingredients, the content of the aqueous component in the food and drink is about 0. 0. Skin fibroblast proliferation promoter, collagen and / or hyaluronic acid production enhancer of the present invention, and skin aging prevention so as to be 01 wt% to about 90 wt%, more desirably about 1 wt% to about 50 wt% What is necessary is just to prepare the target food-drinks according to a conventional method by designing a prescription by appropriately combining at least one of the agents with known raw materials for producing other foods. In foods and beverages in which the content of the aqueous component is less than about 0.01% by weight, a large amount of the food and beverages must be ingested in order to expect the desired effect of the aqueous component, while the amount of the aqueous component If it exceeds about 90% by weight, it may be difficult to produce a practical food or drink. In the case of a human adult, the food / beverage product of the present invention can be arbitrarily selected so that the daily intake of the aqueous component is about 10 mg to about 1,000 mg, desirably about 30 mg to about 500 mg, more desirably about 50 mg to about 300 mg. This method can be taken into the body at the same time as, for example, or before or after meal intake, by oral intake, tube administration, or the like.

Next, although an Example is given and this invention is demonstrated in detail, this invention is not limited by this. In each example, all the percentages, parts and ratios are based on weight.

Production Example 1
After coarsely crushing dried seeds of C. japonica var. Japonica from Goto, Nagasaki Prefecture, steaming and then pressing to obtain a press knead separated from the compressed oil, followed by adding normal hexane to the press koji and extracting by a conventional method After processing, the extract was separated and the extract was collected. The extracted soot was washed with normal hexane to remove oil, and defatted soot was collected. Water (300 mL) was added to 100 g of the defatted rice cake, heated to 80 ° C. under normal pressure and stirred for 1 hour as appropriate, then cooled to room temperature and filtered to separate the filtrate. 200 mL of water was again added to the filtration residue and heated in the same manner. After cooling, the filtrate was collected by filtration. Both filtrates were combined, concentrated under reduced pressure, lyophilized and pulverized to obtain 15.4 g of a powder (referred to as sample 1) containing an aqueous component according to the present invention. When this powder was hydrolyzed and analyzed by HPLC, it contained 16.5% sapogenin, which is an aglycone of saponin, and 1.8% kaempferol, which is a kind of flavonol.

Production Example 2
The dried seeds of Yakushima apple camellia (C. japonica var. Macrocarpa) were defatted by the method described in Production Example 1 and defatted cocoons were collected. 300 mL of water was added to 100 g of the defatted soot and heated at 120 ° C. for 20 minutes under a pressure of 2 atm, then cooled to room temperature and filtered to separate the filtrate. To this filtration residue, 200 mL of water was again added and heated in the same manner. After cooling, the filtrate was collected by filtration. Both filtrates were combined, concentrated under reduced pressure, freeze-dried and pulverized to obtain 16.6 g of a powder (referred to as sample 2) containing an aqueous component according to the present invention. The powder was hydrolyzed in the same manner as in Production Example 1 and analyzed by HPLC. As a result, the sapogenin content was 14.3% and the kaempferol content was 2.4%.

Production Example 3
250 g of water-containing ethanol (water content 35%) was added to 100 g of the defatted lees obtained by the method described in Production Example 1, and the mixture was heated to reflux at 80 ° C. for 1 hour, cooled to room temperature, and filtered to separate the filtrate. To this filtration residue, 200 mL of water-containing ethanol (water content 35%) was added again and heated in the same manner. After cooling, the filtrate was collected by filtration. Both filtrates were combined, concentrated under reduced pressure, freeze-dried and pulverized to obtain 11.7 g of a powder containing the aqueous component according to the present invention (referred to as sample 3). The powder was hydrolyzed in the same manner as in Production Example 1 and analyzed by HPLC. As a result, the sapogenin content was 12.3% and the kaempferol content was 2.5%.

Production Example 4
Ethanol (purity 99.5%) 200 mL was added to 100 g of the defatted lees obtained by the method described in Production Example 2, heated to reflux at 80 ° C. for 1 hour, cooled to room temperature, and filtered to separate the filtrate. 200 mL of ethanol (purity 99.5%) was again added to the filtration residue and heated in the same manner. After cooling, the filtrate was collected by filtration. Both filtrates were combined, concentrated under reduced pressure, freeze-dried and pulverized to obtain 4.7 g of a powder (referred to as sample 4) containing an aqueous component according to the present invention. The powder was hydrolyzed in the same manner as in Production Example 1 and analyzed by HPLC. As a result, the sapogenin content was 14.1% and the kaempferol content was 2.7%.

Production Example 5
In Production Example 1, except that the dried seed was replaced with immature fruit (whole seed-containing seed), the same treatment was performed to obtain a defatted koji, and then 18.4 g of a powder containing an aqueous component (referred to as sample 5). Got. The powder was hydrolyzed in the same manner as in Production Example 1 and analyzed by HPLC. As a result, the sapogenin content was 14.9% and the kaempferol content was 2.3%.

Test Example 1: Skin Fibroblast Growth Promoting Action The effect of the skin fibroblast growth promoter of the present invention (Sample 1 to Sample 5) on the proliferation of skin fibroblasts was examined by the following method. That is, normal human adult dermal fibroblasts (manufactured by Kurabo Industries Co., Ltd., NHDF (AD), hereinafter simply referred to as cells) were used with 10% fetal bovine serum (Daiichi Chemicals Co., Ltd.) using a petri dish (φ10 cm). 2 × 10 ⁵ cells were seeded on D-MEM medium (manufactured) supplemented (Sigma, low glucose) and cultured for 4 days until it became sub-confluent (approximately 80% density). Next, the medium is removed, and the cells are washed twice with 5 mL of PBS and further with 5 mL of 0.02% EDTA solution, and then the cells are recovered using 5 mL of 0.25% trypsin solution (manufactured by Nacalai Tesque). After centrifugation (4 ° C., 1,000 rpm, 5 minutes), the supernatant was removed, and the cells were washed twice with PBS to obtain cells. These cells were repeatedly cultured under the above conditions and subcultured.

Using a 96-well cell culture plate (0.32 cm ² , manufactured by Asahi Techno Glass Co., Ltd.), the subcultured cells were transformed into a human serum fibroblast proliferation low serum medium (Kurabo Co., Ltd., LSGS added 106S medium). : 1 × 10 ⁴ cells / well in a dermal fibroblast basal medium (106S) supplemented with 500 mL of low serum growth additive (LSGS) and cultured for 24 hours. Subsequently, the medium was removed, and the culture was further continued for 48 hours in the low serum medium for human skin fibroblast proliferation to which each sample was added so that the final concentration was 5, 10 or 20 μg / mL. Thereafter, 25 μL of MTT solution (PBS in which thiazolyl blue tetrazolium bromide (manufactured by Sigma, reagent) was dissolved) at a concentration of 5 mg / mL was added and cultured for 1 hour. After completely removing the medium by decantation, a formazan solution (25% (v / v) 0.45 M acetate buffer (pH 4.5), 25% (v / v) N, N-dimethylformamide, 10% ( w / v) Contains sodium n-dodecyl sulfate, pH 4.5) was added and stirred. After standing overnight at room temperature, the absorbance at 590 nm was measured to evaluate the degree of cell proliferation. In the above method, the D-MEM medium and the low serum medium for human dermal fibroblast proliferation were supplemented with penicillin (final concentration 100 IU / mL) and streptomycin (final concentration 0.1 mg / mL). All were performed in a CO ₂ incubator (37 ° C., 5% CO ₂ -enhanced gas phase).

The results are shown in Table 1. In the table, the numerical values are shown as relative values when the value of the control test (when no sample is added) carried out at the same time is taken as 100. From the data in Table 1, the aqueous component of the defatted lees according to the present invention has the effect of promoting the growth of human dermal fibroblasts, and this effect can be achieved by heating the defatted lees under normal pressure or under pressure. It was confirmed that when water was extracted, it became remarkable when ethanol was extracted under heating.

Test Example 2: Hyaluronic acid production enhancing action The effect of the hyaluronic acid production enhancing agent (Sample 1 to Sample 5) of the present invention on hyaluronic acid production enhancement by skin fibroblasts was examined by the following method. That is, dermal fibroblasts subcultured by the method described in Test Example 1 were used for proliferating human dermal fibroblasts using a 96-well cell culture plate (0.32 cm ² , manufactured by Asahi Techno Glass Co., Ltd.). Low serum culture medium (Kurabo Co., Ltd., LSGS-added 106S medium: skin fibroblast basal medium (106S) added with 10 mL of low serum growth additive (LSGS)) seeded at 1 × 10 ⁴ cells / well. Cultured for 1 day. Subsequently, each sample was added to the LSGS-added 106S medium so that the final concentration was 5, 10 or 20 μg / mL, and the culture was further continued for 48 hours. All of this culture solution was collected and used as a test solution for the determination of hyaluronic acid by the following ELISA test.

The hyaluronic acid content in the cell culture solution was analyzed by an ELISA test method using a commercially available hyaluronic acid measurement kit (manufactured by Seikagaku Corporation). That is, the cell culture solution was diluted 16-fold with the buffer solution of the kit, and 50 μL was added to the hyaluronic acid solid-layered microplate. Next, 50 μL of a biotin-labeled HABP solution was added thereto, followed by mixing for 1 minute, and a primary reaction was performed at 37 ° C. for 1 hour. Further, after removing the solution in the well and washing the plate, 100 μL of HRP-labeled streptavidin solution was added, and a secondary reaction was performed at 37 ° C. for 1 hour. Thereafter, the plate was washed by removing the solution in the well, 100 μL of the enzyme substrate solution was added, and the enzyme reaction was performed at room temperature for 30 minutes under light shielding. After adding 100 μL of the reaction stop solution and mixing, the absorbance was measured with a plate reader (measurement wavelength: 490 nm, control wavelength: 620 nm). The hyaluronic acid content in the test solution was determined from a calibration curve using a hyaluronic acid standard product.

The results are shown in Table 2. In the table, the numerical values are shown as relative values when the value of the control test (when no sample is added) carried out at the same time is taken as 100. From the data of Table 2, the aqueous component of the defatted lees according to the present invention has the effect of enhancing hyaluronic acid production by human dermal fibroblasts, and this action is obtained by extracting the defatted lees with water under heating and pressure. It was confirmed that it would be remarkable if

Test Example 3: Preventing skin aging (part 1)
A 5-week-old female hairless mouse (purchased from Nippon SLC Co., Ltd.) was preliminarily raised for 1 week, and then further fed for 1 week on a normal diet (manufactured by Clea Japan Co., Ltd., CE-2). No irradiation + normal diet, positive control group: UV irradiation + normal diet, sample addition group: UV irradiation + sample 2 (1 wt%) + normal diet, and comparison group: UV irradiation + camellia oil (1 wt%) + Divided into 4 groups of normal food (5 animals in each group) and raised for 12 weeks under each condition. UV irradiation was performed on the back of the mouse 5 times weekly for 12 weeks with UV-B at an intensity of 65 mJ / cm ² . The degree of wrinkles and rough skin formed on the mouse skin of each group was evaluated by visual observation.

As a result, wrinkle formation and rough skin were not observed in the control group that was not irradiated with ultraviolet rays. On the other hand, clear wrinkle formation and rough skin occurred in the positive control group irradiated with ultraviolet rays, and there was no significant difference in the comparison group to which camellia oil was added. On the other hand, in the case of the sample addition group in which sample 2 was mixed with normal food, wrinkle formation and rough skin due to ultraviolet irradiation were almost halved. From this, it was confirmed that the said aqueous component which concerns on this invention has the skin aging prevention effect | action which can reduce the skin trouble by ultraviolet irradiation.

Test Example 4: Preventing skin aging (part 2)
Ten volunteer females (22 to 54 years old, average age: 33.5 years old) were given 3 capsules of gelatin capsules filled with 50 mg of sample 4 and 150 mg of indigestible dextrin (ingestion amount of the aqueous component). : 150 mg / day) was taken in 3 divided doses and continued for 2 weeks. This was used as a test group. The control group (10 persons) was similarly given a gelatin capsule filled with 200 mg of indigestible dextrin. After completing the ingestion of the capsule, a questionnaire survey (three-step evaluation) was performed on the influence on the skin of each person.

As a result, (1) About dryness of skin, roughness, and rough skin, the control group was strong: 6 people, normal: 3 people, weak: 1 person, and the test group was strong: 2 people, normal: 2 people, Weak: 6 people. (2) About skin elasticity and flexibility: 1 in the control group: 1; normal: 4; less: 5; more in the test group: 6; normal: 3; less: 1 there were. (3) Regarding skin tension and gloss, strong (increase) in the control group: 2 people, normal: 2 people, weak (less): 6 people, strong in test group (increase): 6 people, normal: 3 people, weak (less): 1 person. (4) Skin wrinkles, sagging and dullness are more common in the control group: 7 people, normal: 2 people, fewer: 1 people, more in the test group: 2 people, normal: 2 people, fewer: 6 people there were. From this, by continuously ingesting the aqueous component according to the present invention, dry skin and rough skin are reduced, the elasticity and flexibility of the skin is increased, and the tension and gloss of the skin are increased, and wrinkles and sagging are increased. Was confirmed to decrease.

Prototype example 1
160 parts of sample 2, 30 parts of beeswax and medium chain fatty acid triglyceride (Nisshin Eulio Co., Ltd., trade name: ODO (registered trademark) 60 parts were heated and mixed to about 50 ° C., and then mixed into a capsule filling machine. Then, a gelatin-coated soft capsule preparation with an internal volume of 250 mg per grain was prepared by a conventional method, and this capsule preparation can be used as a dietary supplement that can be taken orally.

Prototype example 2
50 parts of sample 1, 20 parts of α-lipoic acid (manufactured by Degussa, Germany, trade name: ALIPURE (registered trademark)), 20 parts of lotus germ extract powder (manufactured by Maruzen Pharmaceutical Co., Ltd.), creatine (Degussa, Germany) , "Crea Pure") 25 parts, Riboflavin (DSM Nutrition Japan Co., Ltd.) 18 parts, Maltitol (Towa Kasei Co., Ltd.) 92 parts, Tricalcium Phosphate (Yoneyama Chemical Co., Ltd.) 100 parts and 25 parts of cellulose were charged into a mixer and stirred and mixed for 10 minutes. This mixture was subjected to a direct compression tableting machine to prepare uncoated tablets having a diameter of 7 mm, a height of 4 mm, and a weight of 150 mg / piece, and then a shellac film was formed by the coating machine to produce a tablet-shaped food.

Prototype example 3
30 g of the aqueous component (sample 4) according to the present invention was added to 1 L of commercially available grape juice and mixed well to produce a homogeneous grape flavored beverage. Even when stored in the refrigerator for 3 weeks, the appearance and flavor were neither abnormal nor uncomfortable.

Aqueous components obtained from camellia seeds and / or seed defatted have skin fibroblast proliferation promoting action, collagen and / or hyaluronic acid production enhancing action, skin aging preventing action, etc. Ingestion of the product will restore the original physiological function of the skin, help to improve skin troubles, and early recovery of skin damage. Therefore, oral compositions for beauty and health in the fields of food and drink, pharmaceuticals, quasi-drugs, and feeds Available as a thing.

Claims (9)

  A skin fibroblast proliferation promoter comprising as an active ingredient an aqueous component of camellia (Camellia japonica) berries and / or seed defatted straw belonging to the camellia family Camellia.   A collagen and / or hyaluronic acid production enhancer comprising, as an active ingredient, an aqueous component of camellia (Camellia japonica), which belongs to the camellia family Camellia, and / or seed defatted lees.   The collagen and / or hyaluronic acid production enhancer according to claim 2, wherein the production enhancement of collagen and / or hyaluronic acid is an increase in the amount of collagen and / or hyaluronic acid in the skin tissue.   A skin aging inhibitor comprising, as an active ingredient, an aqueous component of camellia (Camellia japonica) berries and / or seed defatted lees belonging to the genus Camellia. The skin aging preventive agent according to claim 4, wherein the skin aging symptom includes at least one symptom selected from the group consisting of wrinkles, spots, dullness, buckwheat, sagging, roughness and rough skin. The agent according to any one of claims 1 to 6, wherein the aqueous component is an extract obtained by subjecting the defatted lees to extraction with water and / or a lower alcohol. An oral composition for beauty and health comprising the agent according to any one of claims 1 to 6. The oral composition for beauty and health according to claim 7, wherein the oral composition is a food or drink.   Oral intake of an aqueous component of camellia (Camellia japonica) fruit and / or seed defatted cocoons belonging to the genus Camellia belonging to the camellia family, characterized by the promotion of dermal fibroblast proliferation, in vivo collagen and / or hyaluronic acid A method for expressing at least one action selected from the group consisting of a production enhancing action and a skin aging preventing action.